Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2013 Jun 19:14:182.
doi: 10.1186/1745-6215-14-182.

Slimming World in Stop Smoking Services (SWISSS): study protocol for a randomized controlled trial

Affiliations
Clinical Trial

Slimming World in Stop Smoking Services (SWISSS): study protocol for a randomized controlled trial

Deborah Lycett et al. Trials. .

Abstract

Background: Quitting smokers gain weight. This deters some from trying to stop smoking and may explain the increased incidence of type 2 diabetes after cessation. Dieting when stopping smoking may be counterproductive. Hunger increases cravings for smoking and tackling two behaviours together may undermine quitting success. A meta-analysis of randomized controlled trials (RCTs) showed individualized dietary support may prevent weight gain, although there is insufficient evidence whether it undermines smoking cessation. Commercial weight management providers (CWMPs), such as Slimming World, provide individualized dietary support for National Health Service (NHS) patients; however, there is no evidence that they can prevent cessation-related weight gain.Our objective is to determine whether attending Slimming World from quit date, through referral from NHS Stop Smoking Services, is more effective than usual care at preventing cessation-related weight gain.

Methods: This RCT will examine the effectiveness of usual cessation support plus referral to Slimming World compared to usual cessation support alone. Healthy weight, overweight and obese adult smokers attending Stop Smoking Services will be included. The primary outcome is weight change in quitters 12 weeks post-randomization. Multivariable linear regression analysis will compare weight change between trial arms and adjust for known predictors of cessation-related weight gain.We will recruit 320 participants, with 160 participants in each arm. An alpha error rate of 5% and 90% power will detect a 2 kg (SD = 2.5) difference in weight gain at 12 weeks, assuming 20% remain abstinent by then.

Discussion: This trial will establish whether referral to the 12-week Slimming World programme plus usual care is an effective intervention to prevent cessation-related weight gain. If so, we will seek to establish whether weight control comes at the expense of a successful quit attempt in a further non-inferiority trial.Positive results from both these trials would provide a potential solution to cessation-related weight gain, which could be rolled out across England within Stop Smoking Services to better meet the needs of 0.75 million smokers stopping with NHS support every year.

Trial registration: Current Controlled Trials ISRCTN65705512.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram showing flow of participants through trial and main procedures. −, weeks before quitting; 0, quit week; +, weeks after quitting.

References

    1. Klesges RC, Winders SE, Meyers AW, Eck LH, Ward KD, Hultquist CM, Ray JW, Shadish WR. How much weight gain occurs following smoking cessation? A comparison of weight gain using both continuous and point prevalence abstinence. J Consult Clin Psychol. 1997;65(2):286–291. - PubMed
    1. Klesges RC, Winders SE, Meyers AW, Eck LH, Ward KD, Hultquist CM, Ray JW, Shadish WR. Smoking, body weight and their effects on smoking behavior: a comprehensive review of the literature. Psychol Bull. 1989;106:204–230. - PubMed
    1. Brouwer RJN, Pomerleau CS. “Prequit attrition” among weight-concerned women smokers. Eat Behav. 2000;1(2):145–151. doi: 10.1016/S1471-0153(00)00014-3. - DOI - PubMed
    1. Wannamethee SG, Shaper AG, Perry IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 2001;24(9):1590–1595. doi: 10.2337/diacare.24.9.1590. - DOI - PubMed
    1. Davey-Smith G, Bracha Y, Svendsen KH, Neaton JD, Haffner SM, Kuller LH. Multiple Risk Factor Intervention Trial Research Group. Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial. Ann Intern Med. 2005;142(5):313–322. doi: 10.7326/0003-4819-142-5-200503010-00006. - DOI - PubMed

Publication types

Associated data